InvestoGain Australia

SEARCH BY NAME

BROWSE

Browse Australian listed companies0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ
Browse current Australian managed funds0-9A BCDE FGH IJKL MNOP QRST UVWX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

REVA MEDICAL, INC (RVA)

Listed on ASX ( $0.505    -0.005    -0.980%)

Former (or subsequent) names

 

Shareholder links

Our website ranking of RVA: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare, Level 3, 60 Carrington Street, Sydney NSW 2000

Tel : +61 2 8234 5000
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details

Address: c/o Buchan Pty. Ltd. (“Buchan”) Suite 4, Level 14 6 O’Connell Street Sydney, NSW 2000
Tel:  (858) 966-3000 Fax: (858) 966-3099

Date first listed: 23/12/2010
Company Secretary: Katrina Thompson
Sector: Health Care Equipment & Services Industry Group: 
Activities: Development of medical devices, specifically bioresorbable stent products
listed entity carried for record purposes only23/12/2010

ASX Announcements (courtesy of ASX)

Date Price
sens.
Headline Pages PDF
Date Price
sens.
Headline Pages PDF Edited
text*
22/05/2015 asterix Initial Clinical Results for Fantom Scaffold 27 PDF -
18/05/2015   REVA to Present at EuroPCR Conference 1 PDF -
15/05/2015 asterix FANTOM II Clinical Trial Expanded to Australia 2 PDF -
15/05/2015   Quarterly Report on Form 10-Q & AGM Dial-In Details 31 PDF -
14/05/2015 asterix REVA Undertakes Search for Chief Executive Officer 2 PDF -
01/05/2015   Proxy Statement for 2015 AGM 53 PDF -
30/04/2015 asterix Appendix 4C - quarterly 7 PDF -
23/04/2015 asterix Fantom II Clinical Trial Expanded to Europe 2 PDF -
01/04/2015   Initial Director's Interest Notice 2 PDF -
31/03/2015   Annual Report on Form 10-K 99 PDF -
31/03/2015   Form S-8 Filed with SEC 9 PDF -
26/03/2015   Scott Huennekens Appointed to Board of Directors 2 PDF -
24/03/2015   Notice of Briefing Call 1 PDF -
24/03/2015   Appendix 3B 13 PDF -
16/03/2015 asterix Initiation of FANTOM II Clinical Trial & Live Implant at ACC 2 PDF -
27/02/2015 asterix Preliminary Final Report 28 PDF -

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    21/11/2014Robert StockmanOn market CDIs305,500 $0.360$109,980
    13/12/2013Gordon NyeOn market CDIs96,000 $0.520$49,920
    10/12/2013Robert StockmanOn market CDIs115,000 $0.492$56,557
    10/12/2013Robert ThomasOn market CDIs100,000 $0.460$46,039
    13/09/2012Robert ThomasOn market CDIs30,000 $0.515$15,450

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Robert StockmanChairman, CEO01/12/1999
    Katrina ThompsonCFO
    Scott HuennekensNon Exec Director26/03/2015
    Ross BreckenridgeNon Exec Director29/01/2015
    Robert ThomasDirector28/07/2010
    Gordon NyeDirector16/05/2001
    Anne KeatingDirector01/10/2010
    Brian DoveyDirector12/06/2001

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    James SchiroDirector09/11/201025/07/2014